Dreamskin Health Supports Eczema Treatment Clinical Trial


DreamSkin Health, the Hatfield-based manufacturers of premium grade silk clothing for the treatment of eczema, announces its support for CLOTHES – Clothing for the Relief of Eczema Symptoms – a University of Nottingham clinical trial. The trial is being funded by the National Institute for Health Research and DreamSkin is one of two manufacturers supporting the trial.

The trial is led by Professor Kim Thomas from the University of Nottingham’s Centre of Evidence Based Dermatology, who says the trial «is the very first large-scale independent, randomised controlled trial of silk clothing for the management of eczema in children to establish whether or not these new products live up to the claims that are currently being made».

DreamSkin Health, a start-up from the very same brains behind Nike’s Dri-Fit and Adidas’ ClimaTeam, has donated its polymer coated Dreamskin products to the trial, underlining its confidence in this innovative product. Unlike other fabric based eczema treatments, DreamSkin has developed its own patented polymer, which is applied to the highest quality silk fibre using ionic coupling. The DreamSkin polymer creates a firm bond between fibres and chemical at a molecular level. During the manufacturing process, the molecules reorders into a lamella structure that is both hydrophobic and hydrophilic. The hydrophobic element provides an external barrier effect against irritants and the hydrophilic provides a moisture retaining and enhancing property, vital to the effective treatment of eczema.